HLS Therapeutics Inc. (HLS.TO) - Stock Prices, Stock Peers & Analysis

Home
HLS.TO

Company Name	HLS Therapeutics Inc.
Symbol	HLS.TO
Currency	CAD
Price	3.2
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	101,737,600
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	3 - 5.52
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Mr. Craig Stuart Millian M.B.A.
Website	https://www.hlstherapeutics.com

An error occurred while fetching data.

About HLS Therapeutics Inc.

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular (CV) markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsules; and